Results 121 to 130 of about 4,608 (197)

PRRT of neuroendocrine tumors: individualized dosimetry or fixed dose scheme? [PDF]

, 2020
Alexander Haug
openalex   +1 more source

Spinal decompression and radionuclide therapy for an unresectable FGF23 transmitted tumor causing cervical myelopathy: a case report and literature review. [PDF]

Front Oncol
Yokoyama S, Shimizu H, Yuno A, Takenaka J, Wakabayashi N, Watanabe S, Kuwahara K, Matsuoka M, Onodera T, Iwasaki N, Iwata A.   +10 more
europepmc   +1 more source

Paving the Way for CCK2R-Targeted Peptide Receptor Radionuclide Therapy with [¹⁷⁷Lu]Lu-DOTA-MGS5 in Patients with Small Cell Lung Cancer. [PDF]

Pharmaceutics
Zavvar TS, Santo G, Gruber L, Kronthaler A, Hagenbuchner J, Skvortsova I, Piro I, Steiger K, Martinovic V, Minasch D, Löffler-Ragg J, di Santo G, Virgolini IJ, von Guggenberg E.   +13 more
europepmc   +1 more source

PRRT in patients with neuroendocrine tumor: preliminary results of OAR dosimetry and dose-response relationship for NET hepatic metastases

, 2021
E. Tonini, Stefano Panareo, Marcello Longo, L. Longo, Luca Urso, M. Caracciolo, Licia Uccelli, Corrado Cittanti, Alessandro Turra, Mirco Bartolomei   +9 more
openalex   +1 more source

Somatostatin receptor PET-guided treatment and artificial intelligence applications in meningioma: a comprehensive review. [PDF]

Am J Nucl Med Mol Imaging
Gujral J, Gandhi OH, Amanullah AA, Singh SB, Ayubcha C, Werner TJ, Revheim ME, Alavi A.   +7 more
europepmc   +1 more source

Is Dosimetry Necessary in the Treatment of PRRT?

Nuclear Medicine Seminars, 2021
Seval Beykan, Türkay Toklu, Nalan Alan Selçuk   +2 more
openaire   +1 more source

Radioligand therapy for primary brain tumors: a PRISMA-based systematic review of meningiomas and gliomas. [PDF]

Front Med (Lausanne)
Grassi I, Sansovini M, Matteucci F, Marini I, Caroli P, Celli M, Fantini L, Rossetti V, Gurrieri L, Riva N, Rossi A, Bronico I, Iorio VD, Sarnelli A, Arpa D, Nicolini S.   +15 more
europepmc   +1 more source

Radiosensitization of NET cells by HSP90 inhibitor ganetespib is mediated through pleiotropic stress responses. [PDF]

EJNMMI Res
Engbers PAM, Reuvers TGA, Heredia-Genestar JM, Chang J, Verkaik NS, Sabatella M, Nonnekens J.   +6 more
europepmc   +1 more source

Pancreatic Neuroendocrine Tumors: From Benchside to Surgical Treatment. [PDF]

Medicina (Kaunas)
Conzo G, Mongardini FM, Paolicelli M, Klain M, Bellastella G, Conzo A, Bo Z, Lanza E, Piscopo L, Patrone R.   +9 more
europepmc   +1 more source

Targeted β^--Particle Plus Conversion and Auger-Electron Therapy with ¹⁶¹Tb-Labeled Somatostatin Receptor Antagonist DOTA-LM3: A Phase 0 Study. [PDF]

J Nucl Med
Fricke JG, Westerbergh F, McDougall L, Favaretto C, Christ E, Nicolas GP, Geistlich S, Schmid DE, Borgna F, Fani M, Bernhardt P, van der Meulen NP, Müller C, Schibli R, Wild D.   +14 more
europepmc   +1 more source